Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Siemens Introduces the Future of Molecular Imaging at SNMMI

At the 2013 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 8-12, in Vancouver, B.C., Canada, Siemens Healthcare (booth 720) will display two new platforms with the potential to change how molecular imaging is performed.

IBA Molecular, MIM Software Sign Agreement for PETLinQ Enhancement

IBA Molecular North America, Inc. (IBA Molecular) and MIM Software Inc. (MIM Software™) have announced an agreement to co-develop enhancements to the IBA Molecular PETLinQ™ suite of products

SNMMI: PET/MR surpasses PET/CT gold standard for recurrent prostate cancer

PET/MR scans demonstrated a higher capacity for mapping recurrent prostate cancer by finding more areas of prostate cancer metastases than hybrid PET/CT imaging, according to the results of a study presented at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting in Vancouver.

SNMMI: Alzheimer’s precursor? Amyloid connected to hypometabolism in healthy brains

Amyloid plaque burden has been linked with hypometabolism of neurons in areas of the brain associated with Alzheimer’s disease, according to the results of a study presented at the Society of Nuclear Medicine and Molecular Imaging’s 2013 annual meeting in Vancouver.

Spotting Alzheimer’s with an eye test

Researchers at McCusker Alzheimer's Research Foundation in Perth, Australia, have begun a study to evaluate the effectiveness of an eye test for Alzheimer’s disease, according to News.com.au.

MRI diffusion changes may signal cognitive decline

Ischemic small-vessel disease (SVD) wreaks havoc on the brain’s executive function and processing speed and is thought to be caused by gradual disconnects in the white matter tract and other cortical tissues leading to long-term cognitive impairment and disability. However, diffusion changes in apparently healthy tissues can reveal tell-tale signs of impending cognitive decline, according to a study published February 19 in the Annals of Neurology.

FDG PET parameters differ for predicting advanced colon cancer survival

With a host of guidelines for tumor response presented by the now well known Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST), clinicians need to know that not all parameters are alike for predicting patient survival. Case in point, metabolic volume and lesion glycolysis using F-18 FDG PET has been found to be more predictive of survival in patients with metastatic colorectal tumors treated with radioembolization than standardized uptake guidelines, according to a study published May 31 in the Journal of Nuclear Medicine.

Konica Minolta Launches an All-in-one DR Solution for Urgent Care Centers and Community Hospitals

Konica Minolta Medical Imaging announced today the release of a new Digital Radiography Solution -- ImagePilot Aero.  This all-in-one digital imaging system combines the ease of use and simplified image acquisition of the Konica Minolta ImagePilot System with the workflow efficiencies, and high image quality of the lightweight, wireless Aero DR panel.  With this new solution, private practices, imaging centers and community hospitals have access to the productivity and versatility of wireless DR.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.